Ariad Patent Claims In Suit V. Eli Lilly Invalid: Court
The U.S. Court of Appeals for the Federal Circuit has handed a win to drugmaker Eli Lilly & Co. in a long-running patent battle launched by Ariad Pharmaceuticals Inc. over the...To view the full article, register now.
Already a subscriber? Click here to view full article